Ownership history in Qube Research & Technologies Ltd · 38 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 25,100 | -1,000 | -3.8% | 0.01% | $11.4M | $453.36 |
| 2025 Q4 | ADDED | 26,100 | +9,000 | +52.6% | 0.01% | $11.8M | $453.36 |
| 2025 Q3 | REDUCED | 17,100 | -1,400 | -7.6% | 0.01% | $6.7M | $391.64 |
| 2025 Q3 | REDUCED | 18,500 | -32,882 | -64.0% | 0.01% | $7.2M | $391.64 |
| 2025 Q3 | ADDED | 51,382 | +30,782 | +149.4% | 0.02% | $20.1M | $391.64 |
| 2025 Q2 | ADDED | 20,600 | +14,919 | +262.6% | 0.01% | $9.2M | $445.20 |
| 2025 Q2 | REDUCED | 5,681 | -5,819 | -50.6% | 0.00% | $2.5M | $445.20 |
| 2025 Q2 | ADDED | 11,500 | +9,400 | +447.6% | 0.01% | $5.1M | $445.20 |
| 2025 Q1 | REDUCED | 2,100 | -8,000 | -79.2% | 0.00% | $1.0M | $484.82 |
| 2025 Q1 | REDUCED | 10,100 | -24,446 | -70.8% | 0.01% | $4.9M | $484.82 |
As of 2025 Q4 — sorted by position size